Cotización Xeris Biopharma - XERS

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

3.16

Postura de Compra

3.15

Postura de Venta

3.34

Volume Operado de la Acción

2,377,136

3.15 Rango del Día 3.325

1.46 Rango de 52 semanas 3.64

Capitalización de Mercado [m]

470.836M

Precio Anterior

3.15

Precio de Apertura

3.2195

Hora

3.16

Última hora de negociación

Volumen financiero

US$ 7,650,429

Precio Promedio Ponderado

3.2183

Volumen promedio (3 m)

1,604,931

Acciones en circulación

148,998,825

Rendimiento del Dividendo

Ratio Precio/Utilidad

-7.54

Beneficio por acción (BPA)

-0.42

turnover

163.91M

Beneficio neto

-62.26M

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalem... Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. Mostrar más

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

www.xerispharma.com

Sede

Wilmington, Delaware, USA

Fundado

Xeris Biopharma Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XERS. The last closing price for Xeris Biopharma was US$3.15. Over the last year, Xeris Biopharma shares have traded in a share price range of US$ 1.46 to US$ 3.64.

Xeris Biopharma currently has 148,998,825 shares in issue. The market capitalisation of Xeris Biopharma is US$469.35 million. Xeris Biopharma has a price to earnings ratio (PE ratio) of -7.54.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.15	-4.53172205438	3.31	3.64	3.025	3527555	3.3443214	CS
4	0.11	3.60655737705	3.05	3.64	2.962669	1792725	3.25695601	CS
12	0.45	16.6051660517	2.71	3.64	2.48	1604931	2.97948755	CS
26	1.35	74.5856353591	1.81	3.64	1.77	1508354	2.63211045	CS
52	1.49	89.2215568862	1.67	3.64	1.46	1716873	2.47411428	CS
156	0.8	33.8983050847	2.36	3.64	0.9701	1529560	2.25490338	CS
260	-4.91	-60.8426270136	8.07	10.5	0.9701	1790519	3.08014165	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
MVSTMicrovast Holdings Inc	US$ 0.7951 (340.01%)	1.09B
QUBTQuantum Computing Inc	US$ 2.66 (92.75%)	102.21M
PULMPulmatrix Inc	US$ 3.56 (73.66%)	3.63M
BTCTBTC Digital Ltd	US$ 17.65 (68.10%)	45.37M
NMHINatures Miracle Holding Inc	US$ 0.142 (65.69%)	1.33B
SYRSSyros Pharmaceuticals Inc	US$ 0.359 (-86.85%)	38.53M
GCTKGlucoTrack Inc	US$ 0.36 (-77.06%)	6.58M
PETWag Group Company	US$ 0.21 (-67.98%)	14.68M
GLXGGalaxy Payroll Group Ltd	US$ 6.24 (-56.39%)	2.96M
XFORX4 Pharmaceuticals Inc	US$ 0.2773 (-53.17%)	18.56M
NMHINatures Miracle Holding Inc	US$ 0.142 (65.69%)	1.33B
MVSTMicrovast Holdings Inc	US$ 0.7951 (340.01%)	1.09B
ELABElevai Labs Inc	US$ 0.0247 (31.38%)	541.7M
AGRIAgriFORCE Growing Systems Ltd	US$ 0.0486 (2.53%)	291.83M
NVDANVIDIA Corporation	US$ 146.27 (-1.36%)	191.62M